drugset / Trial / NCT05350787
Evaluate the Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With R/R B-ALL
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is an open label, phase I study to assess the safety, efficacy and pharmacokinetics of ThisCART19A in patients with relapsed and refractory acute B-cell leukemia
Timeline
- Start
- 2022-03-18
- Primary completion
- 2025-05-21
- Completion
- 2025-05-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ThisCART19A | Cell therapy | 3 cells/kg | — |
| Subject | ThisCART19A | Cell therapy | 5 cells/kg | — |
Indications
No indication recorded.